Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
OptiBiotix Health ( (GB:OPTI) ) has provided an update.
OptiBiotix Health plc has announced that its shares will begin trading on the OTCQB Venture Market in the United States under the symbol ‘OPTBF’. This move aims to enhance the company’s visibility and liquidity in the U.S. market, building on its existing presence through partnerships and product launches. The trading on OTCQB is expected to broaden OptiBiotix’s U.S. investor base without affecting its current listings on the AIM Market of the London Stock Exchange.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds to modify the human microbiome for disease prevention and wellness promotion. The company engages in extensive R&D to create microbial strains and formulations used in food and healthcare supplements, with agreements with over twenty international companies. Its product focus includes obesity, cardiovascular health, and diabetes.
Average Trading Volume: 349,244
Technical Sentiment Signal: Sell
Current Market Cap: £13.04M
For detailed information about OPTI stock, go to TipRanks’ Stock Analysis page.